Zepbound, a drug approved by the FDA, has been shown to reduce the severity of obstructive sleep apnea in obese adults, ...

( NewsNation) — Zepbound became the first drug approved by the Food and Drug Administration to treat obstructive sleep apnea ...

FDA approves Zepbound for obstructive sleep apnea in obese individuals Discover how this weight-loss drug reduces symptoms ...

The third ‘Downton Abbey’ film honors the late Dame Maggie Smith and her iconic portrayal of Violet Crawley. The drug is ...

Gal-475 is under clinical development by Neurim Pharmaceuticals and currently in Phase I for Sleep Apnea. According to GlobalData, Phase I drugs for Sleep Apnea have a 96% phase transition success ...

Nyxoah's disrupting Genio implant is likely to revolutionize Obstructive Sleep Apnea, and FDA's decision is expected in Q1 ...

Women with pregnancy-onset OSA had significantly higher nocturnal systolic BP and daytime diastolic BP, relative to those ...

Inspire is scheduled to present at 11:15 a.m. Eastern Time. The presentation will be accessible via a live webcast here. Webcast replays of the presentations will be available for two weeks following ...

Dronabinol + palmidrol is under clinical development by Evero Health and currently in Phase II for Tourette Syndrome.

The U.S. Food and Drug Administration (FDA) has approved Zepbound, a prescription weight-loss medication, as the first drug ...

The technique performs well in tracking fluctuations in arterial oxygen saturations that are characteristic for repetitive breathing disturbance in patients with sleep apnea. It is regularly ...